Genes & Risk: What every Secondary Care Clinician should know about BRCA

Join Dr Liz Bancroft for a focused 30‑minute session on the essential BRCA knowledge every secondary care clinician should understand. This webinar explores the clinical significance of BRCA1 and BRCA2, the role of screening in carriers, the impact of BRCA status on prostate cancer treatment, and how to navigate NHS genetic testing pathways. The session also highlights the importance of genetic counselling and the wider implications for families, supporting clinicians to deliver informed, equitable, and patient‑centred care.
Genetic Testing & Health Inequalities: Supporting Equitable Patient Care

Dr Liz Bancroft presents the integration of genetics into prostate cancer care and implications for clinical practice.
Considerations for transgender and gender diverse patients with prostate cancer

Stewarts O’Callagham, CEO at OUTpatients, Alison Berner, Academic Clinical Lecturer at the Barts Cancer Institute , and Lloyd Young, patient with lived experience, share their considerations on the LGBTQI+ prostate cancer patients.
Patients’ Story

Nick Ridgman, Head of Support Services at Prostate Cancer UK, is joined by Robin Porter and Anthony Francis, patients with lived experience, to discuss missing recurrences after prostatectomy.
Reasonable adjustments for people with Learning Disabilities

Serena Jones, Learning Disability & Autism Acute Liaison Nurse at the Liverpool University Hospitals NHS Foundation Trust, explains which reasonable adjustments to action for patients with learning disabilities when visit them.